Delivery Order SPE2DB22D3301-SPE2DB25FX4SF

Award Date 10/30/24
Potential Completion Date 10/31/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award SPE2DB20D3103|SPE2DB25FL7K6 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,138.27 firm fixed price delivery order is for the supply of Ceftriaxone 2 GM-D5W bags, a critical medical commodity. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range...
This federal contract award, with an ID of SPE2DB25D3404|SPE2DB25FUMSJ, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,352.54 firm fixed-price delivery order is for the supply of 4,567,718,870 units of Ceftriaxone 1 GM-D5W bags, a critical medical commodity used in various healthcare settings. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,273.53, is for the delivery of Ceftriaxone 1 GM-D5W bags, a critical antibiotic medication. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,106.00 firm fixed-price delivery order is for the supply of Ceftriaxone 1 GM-D5W Bags, a critical pharmaceutical product. The award is not designated under any set-aside program, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, with ID SPE2DB20D2002|SPE2DB25FL09P, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,354.21 delivery order is for the supply of Ceftriaxone 2 GM-D5W bags, a critical medical commodity used in various therapeutic areas. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,842.19, is a delivery order for the supply of Ceftriaxone 1 GM-D5W bags. The contract has a period of performance through December 5, 2024 and utilizes a firm fixed-price pricing structure. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,208.60 Firm Fixed Price Delivery Order contract is for the supply of Ceftriaxone 1 GM-D5W Bags, a critical medical commodity. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $9,038.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ceftriaxone 2 GM-D5W Bags, a critical pharmaceutical product used in military healthcare settings. The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,418.28 firm fixed-price delivery order is for the supply of 4,567,331,582 units of ceftriaxone 2 GM-D5W bags, a critical antibiotic medication. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order worth $4,165.72 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Ceftriaxone 2 GM-D5W Bags, a critical medical product. The contract has an ultimate completion date of December 12, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX4SF
    Delivery Order

This federal contract award, with an ID of SPE2DB22D3301|SPE2DB25FX4SF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $12,708.66 firm-fixed-price delivery order is for the supply of Ceftriaxone 2 GM-D5W bags, a critical medical commodity. This contract award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This award demonstrates AmerisourceBergen's established role as a key vendor for federal healthcare programs, particularly within the Department of Defense and Veterans Affairs healthcare systems.

Generated 5/20/25, 2:09 PM